Appraisal consultation:
You can now comment on this draft guidance.
Please note that any changes to the continuation of belimumab treatment as a result of NICE’s recommendation (for patients who started treatment as part of the managed access agreement) will not come into effect until NICE publishes final guidance on belimumab. Newly diagnosed eligible patients will be able to start treatment with belimumab under the terms of the managed access agreement until NICE publishes its final recommendation, at which point NICE’s guidance will confirm whether or not belimumab will be available to access via the NHS in the long term.
How to comment
You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments.
We have a new way of making comments on this consultation. You must make your comments directly onto the online version of the consultation document. When you go into the document you will find instructions on how to use the new commenting software. You can also review and edit your comments before you submit them.
You can download a PDF version of the consultation document, but you can only make comments on the online version.
Consultation document
Closing date for comments: 5pm, Friday 25 June 2021
About the consultation
We have asked some questions about the consultation that we would like you to answer. You will be able to see the questions when you go into the online consultation document.
We would also like you to think about whether there are any aspects of the recommendations that need particular consideration to make sure we avoid unlawful discrimination against any group of people. For example, on the grounds of:
- race
- gender
- disability
- religion or belief
- sexual orientation
- age
- gender reassignment
- pregnancy and maternity.
Note that this document is not NICE's final guidance on this technology. The recommendations in section 1 may change after consultation.
After the consultation has closed the appraisal committee will meet again to consider the responses received and prepare the final appraisal document.
Find out more
This page was last updated: